Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the Safety, Acceptability, and Pharmacokinetic Profile of a Gel Formulation of OB-002 in Healthy Volunteers

Published:2021-06-01 Issue:6 Volume:37 Page:453-460
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

McGowan Ian Michael¹²^ORCID,Tzakis Niko³,Kosak Beata¹,Korczak Bozena¹,Engstrom Jarret³,Tomaszewska-Kiecana Monika⁴,Hartley Oliver³⁵

Affiliation:

1. Orion Biotechnology Polska, Krakow, Poland.

2. Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

3. Orion Biotechnology, Ottawa, Canada.

4. BioVirtus Research Site Jóżefów, Jóżefów, Poland.

5. Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2021.0010

Reference33 articles.

1. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa

2. Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings

3. Topical Microbicides in HIV Prevention: State of the Promise

4. Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques;JCI Insight;2022-12-08

2. Rational Engineering of a Sub-Picomolar HIV-1 Blocker;Viruses;2022-10-31

3. Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV;Current Opinion in HIV and AIDS;2022-02-07

4. A Randomized, Open-Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study);AIDS Research and Human Retroviruses;2021-09-14

5. Precision-engineered Peptide and Protein Analogs: Establishing a New Discovery Platform for Potent GPCR Modulators;CHIMIA;2021-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3